775
|
The Journal of Invasive Cardiology - ISSN: 1042-3931 - Volume 19 - Issue 8 - August 2007 | |
|
|
| Mimi Q. Le, MD and Frederick S. Ling, MD |
Spontaneous coronary artery
dissection is a rare and often fatal cause of acute
myocardial ischemia occurring predominantly in
young or middle-aged and otherwise healthy
patients. We report a case of spontaneous dissection
of the left main coronary artery in a young
woman who was successfully treated with percutaneous
coronary stent implantation.
J INVASIVE CARDIOL 2007;19:E18–E221
|
Use of Tandem Heart™ as a Temporary Hemodynamic Support
Option for Severe Pulmonary Artery Hypertension Complicated
by Cardiogenic Shock |
| Sanjay Rajdev, MD, Raymond Benza, MD, Vijay Misra, MD |
ABSTRACT: The TandemHeart™ is a recently-introduced percutaneous
ventricular assist device that may be used for short-term
hemodynamic support. Its utility has been shown for assisting the
left ventricle in a variety of high-risk percutaneous interventions, in
helping the left ventricle recover from myocarditis, in cardiomyopathies
and in cardiogenic shock following acute coronary syndromes.
Limited data exist on its applications in patients with right
ventricular failure. We report our experience, possibly the first
human case description, of a patient in cardiogenic shock secondary
to severe pulmonary artery hypertension where the TandemHeart
was used as a short-term hemodynamic support tool.
J INVASIVE CARDIOL 2007;19:E226–E229
|
Triple Wire Technique for Removal of Fractured Angioplasty
Guidewire |
| Nicholas Collins, BMed, FRACP, Eric Horlick, MD, CM, FRCPC, Vladimir Dzavik, MD, FRCPC, FSCAI |
Device fracture or dislodgement is an infrequent complication of percutaneous coronary intervention. While uncommon,
there are a number of well-described complications including
perforation, thrombosis and arrhythmia. Several percutaneous
retrieval techniques have been previously utilized. We describe the use of three standard 0.014 inch angioplasty guidewires to simply and effectively remove a fractured guidewire located within a distal coronary artery. Various methods of management available in cases of device dislodgement or fracture are discussed, as is the potential
mechanism of guidewire fracture.
J INVASIVE CARDIOL 2007;19:E230–E234
|
Percutaneous Aortic Valvuloplasty as a Bridge to a High-Risk
Percutaneous Coronary Intervention |
| * §Raed A. Aqel, MD, §Fadi G. Hage, MD, * §Gilbert J. Zoghbi, MD |
We describe a novel approach of using percutaneous aortic valvuloplasty as a bridge to percutaneous coronary intervention in a patient with refractory congestive heart failure, severe aortic stenosis, severe left ventricular dysfunction and severe 3-vessel coronary artery disease who was not a surgical candidate for aortic valve replacement and coronary artery bypass grafting.
J INVASIVE CARDIOL 2007;19:E238–E241
|
Anterolateral Myocardial Infarction Induced by Coronary-
Subclavian-Vertebral Steal Syndrome Successfully Treated with
Stenting of the Subclavian Artery |
| *Reji Pappy, MD, §Thomachan Kalapura, MD, MRCP, §Thomas A. Hennebry, MB, BCh BAO, MD |
A female patient with graft-dependent coronary circulation presented with vertebrobasilar
insufficiency and NSTEMI (Non-ST Elevation Myocardial Infarction) related to a 100 percent stenosis
of the left subclavian artery.
Our review of the medical
literature indicates that this is the first reported case
in which a patient presented with an anterolateral NSTEMI and dizziness with subsequent angiographic evidence of both coronary subclavian and vertebral
subclavian steal syndromes successfully treated with
angioplasty and stenting of the left subclavian artery
without any intervention in the coronary arterial tree.
J INVASIVE CARDIOL 2007;19:E242–E245
|
Successful Endovascular Renal Artery Aneurysm Exclusion Using
the Venture™ Catheter and Covered Stent Implantation: A Case Report and Review of the Literature |
| Tiziana Claudia Aranzulla, MD, Antonio Colombo, MD, Giuseppe Massimo Sangiorgi, MD |
ABSTRACT: Renal artery aneurysms are rare vascular anomalies
in which rupture is associated with devastating consequences.
Only a few reported cases involved percutaneous treatment.
Recently, technological advances have expanded indications for
percutaneous treatment of such complex peripheral lesions.
Despite this, certain anatomical settings such as extreme vessel tortuosity or angulation of the afferent vessel continue to pose challenges. New steerable devices may play a crucial role in those cases where conventional techniques have failed. We report a case of successful percutaneous treatment of a renal artery aneurysm and stenosis in a young male using the Venture™ catheter.
J INVASIVE CARDIOL 2007;19:E246–E253
|
|
|
| Ioannis A. Stathopoulos, MD, PhD and Gary S. Roubin, MD, PhD |
|
|
Microcoil Embolization of Distal Coronary Artery Perforation
without Reversal of Anticoagulation: A Simple, Effective Approach |
| Francis A. Ponnuthurai, MBBch, FRACP, DDU, Oliver J. Ormerod, DM, FRCP,
Colin Forfar, MD, PhD, FRCP |
|
|
Successful Stenting of Bilateral Multiple Renal Arteries in a
Patient with Renovascular Hypertension |
| *,§Tom Adriaenssens, MD, *Adnan Kastrati, MD, *Albert Schömig, MD |
ABSTRACT: We describe the use of stenting in multiple renal
arteries with severe ostial stenoses. A 62-year-old male with long-standing arterial hypertension despite treatment with multiple antihypertensive
medications and mild renal impairment, appeared to have 5 renal arteries, 4 of which had severe ostial stenoses. Successful stent implantation
of these 4 lesions was performed in one session. At 3-month follow
up, the patient did well with adequate blood pressure control. In conclusion, stenting of ostial stenoses in multiple renal arteries appears to be
a feasible and useful option in patients with renovascular hypertension.
J INVASIVE CARDIOL 2007;19:E235–E237
|
Usefulness of the SafeCut Dual Wire PTCA Catheter for the
Treatment of Calcified Lesions |
| Shumpei Mori, MD, Yoritaka Otsuka, MD, Atsushi Kawamura, MD |
Calcified lesions are a cause of stent underexpansion,
which significantly increases the subsequent risks of restenosis
and stent thrombosis, even when drug-eluting stents are used. In
this report, we describe how a novel balloon catheter, the SafeCut Dual Wire percutaneous transluminal coronary angioplasty catheter, enabled adequate dilatation in a calcified lesion that was unresponsive to conventional balloon catheters.
J INVASIVE CARDIOL 2007;19:E254–E256
|
|
|
| Mohamad Ali Ostovan, MD and Amir Aslani, MD |
ABSTRACT: We present an unusual case of massive pulmonary
air embolism during permanent pacemaker implantation. Head
down position, precordial thumb and cardiac massage must be done
immediately after the diagnosis of this life threatening condition. If
these maneuvers are not successful, air suctioning with a largelumen
guiding catheter may be effective and life saving.
J INVASIVE CARDIOL 2007;19:355–356
|
|
|
| Richard E. Shaw, PhD, FACC, FACA
Editor-in-Chief |
|
|
|
|
| Tsung O. Cheng, MD
Professor of Medicine
George Washington University
Washington, D.C. 20037
Email: tcheng@mfa.gwu.edu |
|
|
|
|
| Francesco Burzotta, MD, Carlo Trani, MD, Enrico Romagnoli, MD, Maria De Vita, MD,
Giovanni Paolo Talarico, MD, Giuseppe Ferrante, MD, Italo Porto, MD, Antonio Maria Leone, MD,
Giampaolo Niccoli, MD, Giovanni Schiavoni, MD, Antonio Giuseppe Rebuzzi, MD,
Rocco Mongiardo, MD, Mario Attilio Mazzari, MD, Filippo Crea, MD |
Background. A series of thrombectomy and distal filter devices have been developed to limit distal embolization during
percutaneous coronary interventions (PCI). Objective. To evaluate the feasibility of the combined use of thrombus-aspirating catheters and distal
filter devices in patients at high risk of no-reflow. Methods. Thrombus aspiration (TA) and distal filter protection (DFP) were sequentially used in a series of patients undergoing urgent PCI within 48 hours of
acute myocardial infarction (MI). Inclusion criteria were: (1) occlusion of the infarct-related artery; (2) at least 2 out of the 6 Yip’s classification features of high thrombus burden. Coronary angiograms were evaluated off-line to assess thrombus score, coronary flow and distal embolization in different phases of the procedure. Results. TA followed by DFP prior to balloon dilatation or stent implantation was successfully performed in 20 patients with acute MI due to occlusion of de novo lesions
(80%) or in-stent
|
Coronary Stenting with M-Guard: Feasibility and Safety Porcine Trial |
| Edo Kaluski, MD, §Adam Groothuis, MS, MBA, *Marc Klapholz, MD, §Philip Seifart, MS, HTL, ACSP,
£Elazar Edelman, MD |
ABSTRACT: M-Guard is an ultra-thin polymer mesh sleeve
attached to the external stent surface. It is designed to minimize distal
embolization during coronary, renal, carotid and vein graft stenting.
The polymer net could also serve as a platform for more
uniform drug delivery. Aim. To evaluate coronary M-Guard stent
deliverability and safety (stent thrombosis and restenosis) in comparison
to bare-metal stents (BMS) in a porcine model of percutaneous
coronary interventions (PCIs). Methods. Under general
anesthesia using percutaneous technique, 6 swine received a total of
18 coronary stents: 5 BMS and 13 M-Guard-BMS. Quantitative
coronary angiography (QCA) was obtained immediately prior to
and post-PCI, and at 30 days post-stenting. At 30 days, all animals
were sacrificed and hearts were sent to a core lab for coronary histology
and histomorphometry. Primary endpoints were 30-day QCA
percent diameter stenosis, late luminal loss and minimal luminal
diameter (MLD). Secondary
|
Short- and Long-Term Clinical Outcomes of Coronary Drug-
Eluting Stent Recipients Presenting with Chronic Renal Disease |
| *†‡Gregory J. Mishkel, MD, ‡Joji J. Varghese, MD, †Anna L. Moore, MPH, *†‡Frank Aguirre, MD,
‡Stephen J. Markwell, MS, *†‡Marc Shelton, MD |
ABSTRACT: Background. Randomized trials of drug-eluting
stents (DES) excluded patients with severe renal insufficiency. We
sought to evaluate the impact of baseline renal function on clinical
outcomes in recipients of coronary DES. Methods. We retrospectively
reviewed our hospital databases to identify consecutive
patients who underwent DES implantations between May 2003 and
December 2004, subgrouped among 4 ranges of glomerular filtration
rate (GFR) between ≥ 90 ml/min and < 30 ml/min, in 30
ml/min decrements, and 1 group treated with long-term dialysis.
Clinical follow up was obtained at 6 months, 1 year and annually
thereafter. Results. Our study group included 2,758 patients with
long-term outcomes recorded over a mean follow up of 706 ± 273
days. The rates of in-hospital adverse events increased significantly
as GFR decreased, though no major adverse event occurred among
the dialyzed patients. Actuarial survival analyses up to 2 years
revealed significant betw
|
Intra-Aortic Counterpulsation Does Not Improve Coronary Flow
Early after PCI in a High-Risk Group of Patients: Observations
from a Randomized Trial to Explore its Mode of Action |
| Kunadian Vijayalakshmi, MBBS, MRCP, Babu Kunadian, MBBS, MRCP, *Victoria J. Whittaker, MSc,
Robert A. Wright, MD, FRCP, James A. Hall, MA, MD, FRCP, Andrew Sutton, MD, MRCP,
Douglas Muir, MRCP, Mark A. de Belder, MA, MD, FRCP |
ABSTRACT: The intra-aortic balloon pump (IABP) is the most
commonly used temporary cardiac assist device. The precise role
and the mechanism of any benefit in high-risk patients undergoing
percutaneous coronary intervention (PCI) have not been fully determined.
We hypothesized that the use of an IABP following PCI in
high-risk non-shocked patients would immediately increase coronary
blood flow, tissue perfusion and hence preserve left ventricular
function. Methods. Predefined high-risk, but non-shocked, patients
were randomized to either an IABP or no IABP following PCI.
Angiography was performed pre-PCI, immediately post-PCI and 10
minutes after the completion of the procedure. TIMI flow grade
(TFG), TIMI frame count (TFC) and myocardial blush grade
(MBG) were measured. Echocardiographic wall motion index
(WMI) was measured on days 1 and 30 following PCI. Results. Of
33 patients, 17 received IABP and 16 did not. At final angiography,
the TFG was 2.8 ± 0.7 and 2.9 ± 0.3
|
Cost-Effectiveness of the Radial versus Femoral Artery Approach
to Diagnostic Cardiac Catheterization |
| Oleg Roussanov, MD, S. Jeanne Wilson, RN, Katherine Henley, FNP, Greta Estacio, FNP,
Judith Hill, FNP, Brenda Dogan, RN, William F. Henley, PhD, Nabil Jarmukli, MD |
ABSTRACT: Background. The radial approach to cardiac
catheterization is increasingly popular due to shorter procedural and
recovery times and greater patient comfort. Methods. Comparative
cost analysis between radial or femoral (with/without closure device)
approaches were performed. Results. Radial (R), femoral (F), and
femoral with a closure device (F ± C) approaches were used in 70, 62
and 49 consecutive cases, respectively. Group R had higher access
equipment cost ($93.0 ± 9.5 vs. $40.5) in group F (p < 0.001), but
lower catheter cost ($19.7 ± 12.7 vs. $31.1 ± 9.3; p < 0.001) than
Group F, and lower contrast cost ($26.9 ± 17.0 vs. $42.9 ± 25.0) in
Group F ± C (p < 0.001). There was a lower postprocedure recovery
cost ($185.2 ± 52.7) in Group R compared to $337.5 ± 59.0 in
Group F (p < 0.001) and $208 ± 70.4 in Group F ± C (p < 0.001),
with a median recovery time of 126.0 ± 36.0 minutes in group R vs.
240.0 ± 42.0 minutes, and 150.0 ± 48.0 minutes in groups F and F ±
|
|
Create a Successful Vena Cava Filter Practice
Accredited CD
This activity is supported by an educational grant from Cook Incorporated and has been designed for Interventional Cardiologists, Vascular Surgeons, Fellows and Interventional Cardiovascular Nurses and Technologists.
|
| |
|
|
|
|
Achieving Optimal Outcomes in Carotid Stenting: Lessons Learned from Recent Clinical Trials
Complimentary Accredited ON DEMAND Webcast
Topics
1. EVA-3S & Space-Bumps in the road
2. CAPTURE 3500-Lesion morphology & Predictors for Stroke
3. CAPTURE II vs. EXACT 1500-Does open or Closed Cell Stent design really matter?
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Neurologists, Interventional Nurses and Technologists with an interest in the diagnosis and treatment of peripheral artery disease. |
|
Anticoagulation Techniques for Peripheral Vascular Interventions
Complimentary Accredited ON DEMAND Webcast
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.
|
|
|
|
|
|
March 2007 Supplement
|
On-Demand Webcast
|
Archived Webcast
|
|
|
|
|
|
About HMP Communications
HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP’s products and services at www.hmpcommunications.com. ©2008 HMP Communications |
© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd, Suite 100 | Malvern, PA 19355 | 800.237.7285
|
|
| | |